About Us

From screening to cure, we are those lung cancer specialists, patients, and caregivers who consistently strive for improved patient care through research, clinical practice, care delivery, and advocacy.
A collage of several images highlighting key areas of the IASLC

The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies. Since its founding in 1974, the association’s membership has grown to more than 8,000 lung and thoracic cancer specialists from all disciplines and more than 100 countries.

By hosting global conferences, funding cutting-edge research, and educating the health care community and the public about thoracic cancers, the IASLC works to alleviate the burden lung cancer places on patients, families, and communities.

The IASLC's Mission

Be the multidisciplinary world authority on lung and other thoracic cancers through collaborative science, education, and advocacy in order to ensure optimal prevention and patient care.

The IASLC's Vision

Conquering Lung and Other Thoracic Cancers Worldwide in the 21st Century.

Collage of the Board of Directors in action. Photos are framed by white boarders

Board of Directors

The IASLC’s multidisciplinary board brings a wealth of clinical and scientific thoracic oncology expertise, a close familiarity with institutional leadership and tremendous passion for ongoing improvements to care of patients with lung cancer. 

IASLC at WCLC 2023

Staff

The staff of the IASLC is united in a shared passion to conquer lung cancer by serving its members worldwide. 

Comms Committee

Committees

One of the unique benefits of an IASLC membership is the opportunity to serve on an IASLC committee in a volunteer capacity. 

Our History

Our History

In 1972, in response to the overwhelming need for collaboration and a growing concern for public health, Drs. David T. Carr, Oleg S. Selawry, Lawrence Broder, Clifton Mountain and George Higgins began building an international, multidisciplinary organization. 

STATEMENT OF INJUSTICE

The International Association for the Study of Lung Cancer's Statement of Injustice

Financials

2022 Consolidated Financial Statement
Financials
IASLC 2022 Consolidated Financial Statements December 31, 2022 & 2021
Download(339.76 KB)
2021 Annual Report Cover
Financials
Annual Report
Download(318.06 KB)
2021 and 2020 financials cover
Financials
IASLC Consolidated Financial Statements December 31, 2021 & 2020
Download(1.18 MB)
IASLC 2019 Financial Statements
Financials
Transparency is important to the IASLC. See an independent auditor's review of consolidated...
Download(278.79 KB)
IASLC 2019 Tax Return
Financials
Transparency is important to the IASLC. See the society's tax return filings for 2019.
Download(463.23 KB)
2018 Audited Financials
Financials
Transparency is important to the IASLC. See an independent auditor's review of consolidated...
Download(1.79 MB)
2018 Form 990
Financials
Transparency is important to the IASLC. See the society's tax return filings for 2018.
Download(470.41 KB)
2017 Audited Financial Statements
Financials
Transparency is important to the IASLC. See an independent auditor's review of consolidated...
Download(154.04 KB)
2017 Form 990
Financials
Transparency is important to the IASLC. See the society's tax return filings for 2017.
Download(468.7 KB)
2016 Audited Financial Statements
Financials
Transparency is important to the IASLC. See an independent auditor's review of consolidated...
Download(153.2 KB)

Become a Member

From discounts on the Journal of Thoracic Oncology to opportunities to influence care of patients with lung cancer on a global scale, IASLC membership is for everyone in the thoracic oncology community.

Contact Us

Feedback from our members is crucial to our provision of quality programs and resources. Please contact us with questions and comments.